Abstract
Malignant hypertension is a hypertensive emergency, with rapid disease progression and poor prognosis. Although recognized as a separate entity more than a century ago, significant knowledge gaps remain about its pathogenesis and treatment. This narrative review summarizes current viewpoints, research gaps, and challenges with a view to pooling future efforts at improving treatment and prognosis.
Original language | English |
---|---|
Article number | e023397 |
Journal | Journal of the American Heart Association |
Volume | 11 |
Issue number | 7 |
Pages (from-to) | e023397 |
ISSN | 2047-9980 |
DOIs | |
Publication status | Published - 5 Apr 2022 |
Keywords
- Antihypertensive Agents/therapeutic use
- Disease Progression
- Humans
- Hypertension, Malignant/diagnosis
- Hypertension/diagnosis
- Prognosis